Breaking News

Lancaster Labs Launches New Mycoplasma Assay

Lancaster Laboratories has introduced a new cGMP compliant mycoplasma assay, harmonizing both United States Pharmacopeia (USP) Chapter monograph and European Pharmacopoeia Chapter 2.6.7 guidelines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lancaster Laboratories has introduced a new cGMP compliant mycoplasma assay, harmonizing both United States Pharmacopeia (USP) Chapter monograph and European Pharmacopoeia Chapter 2.6.7 guidelines. The USP’s recently published Chapter requires biopharmaceutical companies performing mycoplasma to comply with this new guideline, which is intended to further harmonize U.S. and European requirements for mycoplasma testing. “By offering validated assays performed in compliance with FDA, PTC,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters